Field Guide · Deconstructed

Fecal microbiota transplant.
The deepest reset there is.

The most powerful gut intervention on the map — transplanting a screened healthy donor’s entire microbiome into a child to reboot the gut-brain axis. The most durable gut-to-behavior result ever published in autism came from this. Here are the facts: the research, where to actually access it, how it’s dosed, the real risks — and the one thing that makes its safety unlike anything else on this site: you can’t take it back out. Read that part first.

I walked this part of the labyrinth myself — knocked on the doors, read the research, and came back with the map. You don’t have to find the way out alone.

The one thing that makes FMT different

You cannot easily undo a transplanted microbiome. Almost everything else in this Field Guide has an antidote — you stop the herb, you take the dewormer, you wash out the drug. FMT is the exception. Once a donor’s microbial community engrafts, it’s in there. There is no clean “remove it” button.

That single fact reorganizes the entire safety story: all of the safety has to happen up front. The screening of the donor, the supervision of the procedure, the quality of the material — those aren’t nice-to-haves, they’re the whole game, because you can’t fix a bad donor after the fact.

  • DIY / homebrew FMT → never, and never in a kid. Skipping donor screening is the unrecoverable mistake.
  • For anything but recurrent C. diff, this is experimental — trials or a supervised, screened clinic only.
  • MCAS / histamine-reactive kids: a brand-new microbiome can flare them. Go slow.

What it is

Fecal microbiota transplant (FMT) moves a screened, healthy donor’s entire gut microbial community into the recipient — the deepest reset of the microbiome available. A probiotic adds a few strains back; FMT transplants the whole ecosystem at once: the bacteria, the diversity, the balance of keystone and opportunist species, all of it. It’s the difference between adding a few plants to a depleted field and laying down a whole established meadow.

The rationale in PANS and autism follows directly from the gut entry: in a lot of these kids the gut isn’t a side issue, it’s the root. A disturbed microbiome (dysbiosis) doesn’t just cause stomachaches — through the vagus nerve, the immune system, and the metabolites gut bugs make, it can drive the exact neuropsychiatric symptoms (OCD, rage, anxiety, regression) that look purely psychiatric. If the dysbiosis is the engine, then resetting the whole community — rather than nudging it strain by strain — is the most direct lever there is. That’s the appeal. The evidence that it delivers is real but early — honestly covered below.

The mental model: FMT sits at the deep end of the remove → rebuild → reset arc. You reach for it when you’ve cleared the pathogens, rebuilt with diet and targeted probiotics (and even probiotic retention enemas), and the dysbiosis still won’t hold. It’s not a first move — it’s the move when the gentler resets haven’t stuck.

The research — honest level: one durable, very promising signal — not yet proof

The most-cited autism work, and the reason FMT is on this menu at all, comes from Arizona State University — Kang, Krajmalnik-Brown & Adams. It’s genuinely the most durable gut-to-behavior result published. It’s also small and uncontrolled. Both things are true at once.

The ASU trial — what actually happened

The ASU team ran an open-label trial in 18 children with autism and chronic GI problems, using an extended “Microbiota Transfer Therapy” (MTT) protocol. Both gut symptoms and behavior improved — and, unusually, the gains held and even deepened at the 2-year follow-up:

  • A professional evaluator found a ~45% reduction in core ASD symptoms (language, social interaction, behavior, measured on the CARS) at two years versus baseline.
  • An average ~58% reduction in GI symptoms (Gastrointestinal Symptom Rating Scale) versus baseline, still holding at two years.
  • All 18 families completed the original study and returned two years later — rare follow-through for this population — with lasting increases in gut bacterial diversity and in Bifidobacteria and Prevotella.

Sources: Kang et al., Microbiome 2017 (original open-label trial, PMID 28122648) · Kang et al., Scientific Reports 2019 (2-year follow-up, PMID 30967657) · ASU News summary.

The honest labels — what this is NOT

  • Small. Eighteen children. A strong signal at that size, but a signal — not a population.
  • Open-label, no control arm. Everyone knew they were getting treatment, and there was no placebo group. Some of the improvement could be expectation, natural change, or the surrounding care — the design can’t separate those out.
  • Not PANS-specific. This was an autism + GI population. The gut-brain mechanism plausibly carries over to PANS, but no one has run the trial in PANS kids. That’s an extrapolation, and we’re labeling it as one.
  • Not proof. It’s the result that justifies the larger, controlled trials now underway — the kind of finding you take seriously and watch, not the kind you treat as settled.

The honest read: this is the most encouraging durable result in the whole gut-to-brain space — and it’s still one small, open-label study. “Very promising, worth taking seriously, not yet proven” is the accurate headline. Anyone who tells you FMT is a proven autism or PANS treatment is ahead of the evidence.

How it’s dosed — the MTT protocol

Read this as “what the ASU trial actually did,” not a prescription. The reason their result held may be that they didn’t do a single one-shot transplant — they ran an extended Microbiota Transfer Therapy (MTT) course designed to clear the old community first, then seed and hold the new one over weeks. The shape of it:

StepWhat it isWhy
1. Clear~14 days of oral vancomycinKnock back the existing pathogenic/dysbiotic bacteria to make room.
2. PrepBrief fast + a bowel cleanse (e.g. MoviPrep)Flush out the antibiotic and the remaining bacteria so you’re seeding into clean ground.
3. High initial doseA high dose of standardized donor microbiota to start (with a stomach-acid suppressant to help the bugs survive the trip)Establish the new community in force, not in a trickle.
4. MaintenanceLower daily maintenance doses for ~7–8 weeksKeep feeding and topping up the new community so it actually engrafts and holds, instead of washing out.

Two delivery routes. The microbiota can be given orally (capsules / liquid) or rectally (colonoscopic infusion or enema) — the ASU protocol used both at different points. Oral is easier and far more kid-tolerable; colonoscopic/enema delivery puts the community directly in the lower bowel. The key insight isn’t the route — it’s that the durable result came from an extended, maintained course, not a single transplant. Kang et al., Microbiome 2017 (MTT protocol)

Where & how to access it — honestly

This is the part nobody explains clearly, and it’s where families get hurt. FMT’s legal and clinical status depends entirely on what you’re using it for.

RouteWhat it isThe honest note
FDA-approved products
Rebyota, Vowst
Recurrent C. difficile ONLY. Two FDA-approved fecal microbiota products exist — Rebyota (enema) and Vowst (oral) — both approved for adults with recurrent C. diff after antibiotics.This is the only approved use. There is no FDA-approved FMT for autism, PANS, or general dysbiosis. Don’t let a clinic imply the approval covers your situation — it doesn’t.
Clinical trialEnroll in a registered study (several FMT-for-autism trials are underway, building on the ASU work).The safest experimental route: screened donors, IRB oversight, controlled material, and you’re contributing to the evidence the whole field needs. Search ClinicalTrials.gov.
Supervised clinic
screened-donor, international / private
A supervised setting with screened donors and controlled material — e.g. Taymount (UK), or ProgenaBiome / Dr. Sabine Hazan (who runs FMT under individual FDA Investigational New Drug applications).Experimental and largely out-of-pocket. The non-negotiable is verified donor screening + medical supervision. Vet hard — the quality of the donor program is the entire safety story.

DIY FMT is dangerous — NEVER in kids

Home “homebrew” transplants skip donor screening entirely — and donor screening is the one part of FMT you cannot get wrong, because you can’t take a bad microbiome back out. The risks are real and serious: transmission of infections and pathogens, and physical injury including bowel perforation. Clinicians describe DIY FMT as a game of Russian roulette. Do not attempt it at home, and never on a child.

Sources: FDA — approved fecal microbiota products (C. diff only) · Healio — DIY FMT, a “risky game of Russian roulette” · Taymount Clinic — FMT programmes.

Choose your path

This tree is for a family weighing FMT after the gentler steps haven’t held. Start at the top and follow your situation; each step is backed by the evidence on this page. Tap to open.

1 · Have you actually done remove → rebuild first?

Not yet → do that first. Clear pathogens/parasites/candida, rebuild with diet + targeted probiotics, and try probiotic retention enemas — the gentler, lower-cost step in the same family. FMT is for when these don’t hold.
Done all that, still stuck → FMT is a reasonable next question ↓

2 · The DIY question — settle it now.

Considering a homebrew transplant?STOP. There is no safe DIY FMT for a child — unscreened donors carry infection and injury risk you cannot reverse. The only acceptable routes are a clinical trial or a supervised, screened-donor clinic.

3 · Pick the safest route you can reach.

First choice: a clinical trial (screened donors + oversight + you help build the evidence). Otherwise: a supervised clinic (Taymount; ProgenaBiome / Dr. Hazan) — and confirm the donor-screening program in writing. Jump to the protocol.

4 · Is your child MCAS / histamine-reactive?

Yes → extra caution. A brand-new microbial community can flare a reactive child. This doesn’t rule it out, but it means go slow, start low, and watch closely with a provider who knows mast-cell kids. Jump to the risks & the antidote.

5 · Watch and report — over weeks, not days.

The MTT result built over a ~7–8 week maintained course and deepened over years — this is slow. GI symptoms or a flare → that’s expected adjustment to a point; tell your provider and slow down. Improving / steady → continue the supervised schedule.

This is a lot to weigh — and you don’t have to weigh it alone. Minta has all of this synthesized. She’ll look at your child’s gut panel and history, tell you honestly whether FMT even belongs on your table yet (or whether you’ve got gentler steps left), and if it does, help you find a screened, supervised route and plan the slow start — then walk it with you. Let Minta do this with you →

The risks — and the “antidote” that isn’t one

This is the section that matters most, because FMT breaks the usual pattern. On every other page, “the antidote” means a way to reverse the intervention if it goes wrong. With FMT, the honest answer is: you mostly can’t. You can’t un-transplant a microbiome the way you stop an herb or give a dewormer. So the “antidote” for FMT is split in two: prevention up front (where almost all the safety lives) and managing the adverse effects after.

RiskWhat it isHow you manage it
Infection transmissionA poorly-screened donor can pass pathogens or infections into your child — the catastrophic, hard-to-reverse failure mode.Prevention is the only real answer. Rigorous donor screening + medical supervision. This is non-negotiable and it’s why DIY is out.
MCAS / histamine flareA whole new microbial community can flare a mast-cell- or histamine-reactive child.Go slow, start low, with a provider who knows reactive kids. Manage with the child’s usual mast-cell/histamine support; pause and reassess if it’s clearly worsening.
GI symptomsBloating, cramping, changes in stool — common as the gut adjusts, especially early.Usually transient and managed supportively. A child who can report how they feel makes this far safer to steer.
Physical injury (procedural)With rectal/colonoscopic delivery — and especially with unskilled DIY — bowel injury/perforation is a documented risk.Trained, supervised delivery only. Another reason home attempts are off the table.

The rule, stated plainly

  • You can’t easily reverse FMT. Unlike the rest of this Field Guide, there is no clean “take it back out” step.
  • So the safety is all up front. The “antidote” is prevention — donor screening and supervision — not a rescue you run afterward.
  • After the fact, you manage adverse effects (slow the pace, support the GI/mast-cell symptoms, treat any specific infection that’s identified) — you don’t un-transplant the community.
  • If you can’t verify the donor screening, you don’t do the FMT. Full stop. That’s the whole decision in one line.

Pros, cons & when to consider it

The case for it

  • The deepest reset available — transplants a whole community, not a few strains, so it can move dysbiosis that nothing gentler has shifted.
  • The most durable gut-to-behavior signal published — the ASU result held and deepened at two years, which is rare.
  • A real mechanism behind it — the gut-brain axis (vagus, immune, metabolites) is well-characterized; FMT acts on the root, not a downstream symptom.

The case against / what to weigh

  • Experimental for your use — FDA-approved only for recurrent C. diff; everything else is trial-or-clinic.
  • Cost & access — trials are limited; supervised clinics are often international and out-of-pocket.
  • Irreversible — the can’t-undo-it problem, which raises the stakes on getting the donor right.
  • The MCAS caution — reactive kids can flare on a new microbiome.
  • The evidence is one small open-label study — promising, not proven, and not yet in PANS.

When to consider it: for stubborn dysbiosis — when you’ve worked the remove → rebuild arc, tried probiotic retention enemas, and the microbiome still won’t hold. At that point you weigh the durable autism-trial signal against the experimental status, the cost and access, and the MCAS caution — and if you proceed, you do it through a screened, supervised route, slowly. It’s a real option on the “what hasn’t been tried” menu, not a first move.

How to vet a practitioner

Credentials, polish, and how conventional an approach sounds tell you little about whether a practitioner will help your child — or harm them. What does: their behavior and their incentives. Watch those.

FMT sounds dramatic — a stool transplant for your child — so a slick clinic and confident credentials tell you nothing. Don’t judge by how impressive it sounds; judge the conduct and the incentives.

Red flags

  • Promises a cure, or claims FMT is a proven autism/PANS treatment (it isn’t — the evidence is one small open-label study).
  • Implies the FDA approval covers your child’s condition — it only covers recurrent C. diff.
  • Is vague about donor screening, or can’t show you the screening protocol in writing — the one thing you cannot get wrong.
  • Floats or enables DIY / homebrew FMT, or downplays the irreversibility.
  • Tells you to stop your other care, sells you the FMT and the testing and a supplement stack, and uses fear/urgency.

Green flags

  • Honest that this is experimental and promising-not-proven for anything but C. diff.
  • Leads with donor screening — shows you the protocol, runs under proper oversight (trial / IND / supervised program).
  • Names the irreversibility and the MCAS caution before you ask; starts low and slow.
  • Sends you to gentler steps first when you haven’t exhausted remove → rebuild, and welcomes your other doctors and second opinions.

Bottom line

FMT is the deepest microbiome reset there is, and it carries the most durable gut-to-behavior result published — the ASU trial’s ~45% CARS and ~58% GI reductions, still holding at two years. But it’s one small, open-label study, not PANS-specific, and not proof. It’s FDA-approved only for recurrent C. diff; for everything else it’s experimental — a clinical trial or a supervised, screened-donor clinic, never DIY, never in a kid without screening. And it’s the one tool on this whole map you can’t take back out — so the safety lives entirely up front, in the donor screening, and afterward you manage adverse effects rather than reverse them. Consider it for stubborn dysbiosis once remove → rebuild → probiotic retention enemas haven’t held — slowly, with MCAS caution, through a screened route. This is parent education, not medical advice — bring it to your team as questions, not instructions.

How Plan B stays honest

Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.

← Back to the Field Guide